American Thinker by Antonio R. Chaves Is Gilead, the maker of Remdesivir, waging war on HCQ (hydroxychloroquine)? Attacks on the drug have been continuous ever since Dr.
“We realise that chloroquine can be used in the early stage of the COVID-19 infection as prophylactic treatment. Science does not lie.”
A Belgian study has just been published, on 8,000 patients, and concludes that hydroxychloroquine reduces mortality by 30%
The study concluded that hydroxychloroquine can be effective when given early after a COVID-19 diagnosis, and there was no negative side effects.
Source: Real Clear Politics Author: Mikko Paunio As an epidemiologist, I believe that America has been profoundly ill-served by the contribution of its public health
Source: Life Site News. Author: Martin Bürger An epidemiologist at Yale School of Public Health praised the proven benefits of hydroxychloroquine (HCQ) in fighting COVID-19,
My dose is only two grams, far less than the doses most studies use. There’s a toxic level of HCQ and if you get above that there will be side effects.
HCQ and AZI are safe in haemodialysis patients at these doses, and HCQ concentrations were not correlated with side effects.
